Barton et al or Fischhoff et al v. Adang et al. - Page 86




          Interference 103,781                                                        
          this interference, Adang must show that it was first to conceive            
          the invention defined by any one of Claims 1-4, 7, and 15-22 of             
          Barton’s U.S. Application 07/827,906, filed January 30, 1992; any           
          one of Claims 3, 5, and 39-40 of Fischhoff’s U.S. Application               
          08/434,105, filed May 3, 1995; or any one of Claims 1-12 of                 
          Adang’s U.S. Patent 5,380,831, issued January 10, 1995, and that            
          it exercised reasonable diligence toward later reducing that                
          invention to practice.  Eaton v. Evans, 204 F.3d 1094, 1097, 53             
          USPQ2d 1696, 1698 (Fed. Cir. 2000).  Mahurkar v. C.R. Bard, Inc.,           
          79 F.3d 1572, 38 USPQ2d 1288 (Fed. Cir. 1996), adds at 1578,                
          38 USPQ2d at 1291:                                                          
                    Where a party is first to conceive but second to                  
               reduce to practice, that party must demonstrate reasonable             
               diligence toward reduction to practice from a date just                
               prior to the other party’s conception to its reduction to              
               practice.  Griffith v. Kanamaru, 816 F.2d 624, 625-26,                 
               2 USPQ2d 1361, 1362 (Fed. Cir. 1987).                                  
               Thus, our initial task is to determine if Adang was first to           
          conceive of the invention of a claim corresponding to Count 2.              
          To establish prior conception of the invention of Count 2, Adang            
          must show that prior to December 12, 1986, it had “a definite and           
          permanent idea of the complete and operative invention,”                    
          Burroughs Wellcome Co. v. Barr Labs., Inc., 40 F.3d at 1228,                
          32 USPQ2d at 1919; i.e., Adang must show it had possession of an            
          invention having every feature recited in a claim to which Count            
          2 of this interference is alternatively directed and knowledge of           
                                        -86-                                          





Page:  Previous  79  80  81  82  83  84  85  86  87  88  89  90  91  92  93  Next 

Last modified: November 3, 2007